STOCKHOSPITAL & MEDICAL SERVICE PLANSUpdated 2026-06-07
Here’s whether Clover Health Investments, Corp (CLOV) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+15.90% over 10 days); RSI 59 — healthy momentum range; strong 1-year return of +26.8%; 3-month momentum positive (+91.5%). Currently 9.5% off its 52-week high. Score: +7/7.
CLOV is in a confirmed uptrend, trading above both its 50-day ($2.77) and 200-day ($2.62) moving averages. An RSI of 58.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +26.8% compares to +24.4% for SPY (beat the market by 2.5%).
$10,000 invested 1 year ago→ $12,682 today
vs. S&P 500 (SPY) — same period beat market by 2.5%